• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊拉克库尔德地区扎胡市库尔德人群中血红蛋白病的患病率

Prevalence of Hemoglobinopathies Among the Kurdish Population in Zakho City, Kurdistan Region, Iraq.

作者信息

Zebari Shakir Abdulrahman

机构信息

Hematopathology, College of Medicine, University of Zakho, Zakho, IRQ.

出版信息

Cureus. 2025 Feb 11;17(2):e78862. doi: 10.7759/cureus.78862. eCollection 2025 Feb.

DOI:10.7759/cureus.78862
PMID:40084341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11906173/
Abstract

BACKGROUND

Hemoglobinopathies are the most common inherited disorders in the Mediterranean region, including Iraq, with different frequencies and molecular features. They represent an important health problem in Iraq. Several studies have addressed the prevalence of hemoglobinopathy in Iraq, but no specific research has addressed its prevalence in Zakho city, Kurdistan Region, Iraq. Thus, this study was conducted to address this issue.

MATERIALS AND METHODS

A prospective cross-sectional study was conducted in a premarital screening center at Zakho Emergency Teaching Hospital, involving 11,910 Kurdish persons attending premarital screening investigations. Blood samples were collected from all participants for complete blood counts and sickling tests. A cut-off value of hemoglobin (Hb) concentrations (<13.0 gm/dl in males, <12.0 gm/dl in females), mean cell volume (MCV) <80 fl and/or mean cell hemoglobin (MCH) <27 pg, and the results of the sickling test were used to categorize the participants into three groups: group I, normal (normal Hb, MCV, and MCH, and negative sickling test); group II, individuals with MCV < 80 fl and/or MCH < 27 pg, with or without anemia, and negative sickling test; group III, sickle positive (individuals with a positive sickling test, with or without anemia, regardless of MCV and/or MCH values). Groups II and III underwent further evaluations by morphology, reticulocyte count, hemoglobin-H preparation, iron studies, and cation exchange high-performance liquid chromatography (HPLC). β-thalassemia trait was diagnosed by hypochromic microcytic red cell indices and increased hemoglobin A2 (HbA2) (>3.5%). The sickle cell trait was diagnosed by the presence of a band at the S region at HPLC with a positive sickling test. Iron deficiency anemia (IDA) was diagnosed by hypochromic microcytic anemia and reduced transferrin saturation (<15%) and/or ferritin (<15 mg/L). Descriptive statistical analyses were conducted to define significant differences between the study's findings.

RESULTS

A total of 963 (8.09%) of the studied participants were in group II. Further investigations on these 963 cases confirmed a diagnosis of IDA in 610 (5.12%). β-thalassemia trait was detected in 308 cases, with an overall prevalence of 2.59%. δβ-thalassemia trait was detected in nine (0.076%) of the studied participants. A professional diagnosis of α-thalassemia was given to 36 (0.30%) of those with hypochromic microcytic red cell indices, normal iron studies, and HPLC results. A positive sickling test was seen in 48 participants and confirmed by HPLC as a sickle cell trait with a prevalence of 0.4%. The consanguinity rate among couples was 28.8%. Neither case of HbC or HbD trait, nor combined hemoglobinopathy, was detected in the current study. Furthermore, no differences were found between the prevalence of both β thalassemia and sickle cell trait with either sex and/or religion, with a p-value of 0.07, 0.07, 0.532, and 0.78, respectively.

CONCLUSION

The prevalence of hemoglobinopathy in Zakho city is lower than in other regions of Iraq but still constitutes a significant burden on health services and financial resources. Careful interpretations of red cell indices, together with intensified premarital screening and counseling programs, coupled with an urgent need to increase awareness about the effects of consanguinity marriages on the prevalence of autosomal recessive disorders, can further reduce the incidence of hemoglobinopathies.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8155/11906173/ae76eb4b1584/cureus-0017-00000078862-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8155/11906173/288e711a5b74/cureus-0017-00000078862-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8155/11906173/ae76eb4b1584/cureus-0017-00000078862-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8155/11906173/288e711a5b74/cureus-0017-00000078862-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8155/11906173/ae76eb4b1584/cureus-0017-00000078862-i02.jpg
摘要

背景

血红蛋白病是地中海地区最常见的遗传性疾病,包括伊拉克,其发病率和分子特征各不相同。它们在伊拉克是一个重要的健康问题。几项研究探讨了伊拉克血红蛋白病的患病率,但没有具体研究涉及伊拉克库尔德地区扎胡市的患病率。因此,开展本研究以解决这一问题。

材料与方法

在扎胡急救教学医院的婚前筛查中心进行了一项前瞻性横断面研究,涉及11910名参加婚前筛查调查的库尔德人。采集所有参与者的血样进行全血细胞计数和镰变试验。根据血红蛋白(Hb)浓度(男性<13.0克/分升,女性<12.0克/分升)、平均红细胞体积(MCV)<80飞升和/或平均红细胞血红蛋白(MCH)<27皮克的临界值以及镰变试验结果,将参与者分为三组:第一组,正常(Hb、MCV和MCH正常,镰变试验阴性);第二组,MCV<80飞升和/或MCH<27皮克的个体,有无贫血,镰变试验阴性;第三组,镰变阳性(镰变试验阳性的个体,有无贫血,无论MCV和/或MCH值如何)。对第二组和第三组进行形态学、网织红细胞计数、血红蛋白-H制备、铁代谢研究和阳离子交换高效液相色谱(HPLC)进一步评估。β地中海贫血特征通过低色素小红细胞指数和血红蛋白A2(HbA2)升高(>3.5%)诊断。镰状细胞特征通过HPLC在S区域出现条带且镰变试验阳性诊断。缺铁性贫血(IDA)通过低色素小红细胞性贫血和转铁蛋白饱和度降低(<15%)和/或铁蛋白降低(<15毫克/升)诊断。进行描述性统计分析以确定研究结果之间的显著差异。

结果

共有963名(8.09%)研究参与者属于第二组。对这963例病例的进一步调查确诊610例(5.12%)为IDA。检测到308例β地中海贫血特征,总体患病率为2.59%。在9名(0.076%)研究参与者中检测到δβ地中海贫血特征。对36名(0.30%)低色素小红细胞指数、铁代谢研究正常且HPLC结果正常的个体进行了α地中海贫血的专业诊断。48名参与者镰变试验阳性,经HPLC确认为镰状细胞特征,患病率为0.4%。夫妻间近亲结婚率为28.8%。本研究未检测到HbC或HbD特征病例,也未检测到合并血红蛋白病。此外,β地中海贫血和镰状细胞特征的患病率在性别和/或宗教方面均无差异,p值分别为0.07、0.07、0.532和0.78。

结论

扎胡市血红蛋白病的患病率低于伊拉克其他地区,但仍对卫生服务和财政资源构成重大负担。仔细解读红细胞指数,加强婚前筛查和咨询项目,以及迫切需要提高对近亲结婚对常染色体隐性疾病患病率影响的认识,可进一步降低血红蛋白病的发病率。

相似文献

1
Prevalence of Hemoglobinopathies Among the Kurdish Population in Zakho City, Kurdistan Region, Iraq.伊拉克库尔德地区扎胡市库尔德人群中血红蛋白病的患病率
Cureus. 2025 Feb 11;17(2):e78862. doi: 10.7759/cureus.78862. eCollection 2025 Feb.
2
Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.婚前筛查对于降低伊拉克重型地中海贫血患儿出生率至关重要。
Hemoglobin. 2024 Jan;48(1):56-59. doi: 10.1080/03630269.2024.2325456. Epub 2024 Apr 2.
3
Thalassemia and Hemoglobinopathy Screening in Women Attending Antenatal Clinic at a Tertiary Care Center in Uttarakhand, India: A Re-look at the Laboratory Parameters Mandating High-Performance Liquid Chromatography Workup.印度北阿坎德邦一家三级医疗中心产前检查门诊女性的地中海贫血和血红蛋白病筛查:重新审视需要高效液相色谱分析的实验室参数。
Cureus. 2023 Jun 19;15(6):e40667. doi: 10.7759/cureus.40667. eCollection 2023 Jun.
4
Genetic Blood Disorders Survey in the Sultanate of Oman.阿曼苏丹国的遗传性血液疾病调查。
J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.
5
Distinguishing Iron Deficiency Anemia From Beta-Thalassemia Trait: Comparative Analysis of CRUISE Index and Other Traditional Diagnostic Indices.鉴别缺铁性贫血与β地中海贫血特征:CRUISE指数与其他传统诊断指标的比较分析
Cureus. 2024 Jul 7;16(7):e64048. doi: 10.7759/cureus.64048. eCollection 2024 Jul.
6
Premarital Screening of Beta Thalassemia Minor in north-east of Iran.伊朗东北部轻型β地中海贫血的婚前筛查
Iran J Ped Hematol Oncol. 2013;3(1):210-5. Epub 2013 Jan 22.
7
Undiagnosed Hemoglobinopathies: A potential threat to the premarital screening program.未确诊的血红蛋白病:对婚前筛查项目的潜在威胁。
Pak J Med Sci. 2019 Nov-Dec;35(6):1611-1615. doi: 10.12669/pjms.35.6.976.
8
Application of HbA levels and red cell indices-based new model in the differentiation of thalassemia traits from iron deficiency in hypochromic microcytic anemia Cases.基于血红蛋白A水平和红细胞指数的新模型在低色素小细胞性贫血病例中鉴别地中海贫血特征与缺铁性贫血的应用。
Int J Lab Hematol. 2020 Oct;42(5):526-532. doi: 10.1111/ijlh.13270. Epub 2020 Jun 21.
9
Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia.沙特阿拉伯哈萨地区婚前筛查中β地中海贫血特征的患病率。
Ann Saudi Med. 2006 Jan-Feb;26(1):14-6. doi: 10.5144/0256-4947.2006.14.
10
Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.印度古吉拉特邦绍拉什特拉地区β-地中海贫血症和其他血红蛋白病的谱:一项大型人群筛查计划的分析。
Hemoglobin. 2022 Sep;46(5):285-289. doi: 10.1080/03630269.2022.2142608. Epub 2022 Nov 11.

本文引用的文献

1
Prevalence and Spectrum of β-Thalassemia Mutations in Baghdad, Iraq: Data from the Premarital Screening Program.伊拉克巴格达β地中海贫血突变的患病率及谱系:来自婚前筛查项目的数据
Hemoglobin. 2025 Jan;49(1):31-37. doi: 10.1080/03630269.2024.2446360. Epub 2025 Jan 7.
2
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.显著血红蛋白病:筛查和诊断指南:英国血液学学会指南:英国血液学学会指南。
Br J Haematol. 2023 Jun;201(6):1047-1065. doi: 10.1111/bjh.18794. Epub 2023 Apr 19.
3
Hematological Parameters and Demographic Distribution of Hemoglobinopathies and Various Hemoglobin Variants.
血红蛋白病和各种血红蛋白变体的血液学参数及人口统计学分布
Cureus. 2022 Dec 29;14(12):e33115. doi: 10.7759/cureus.33115. eCollection 2022 Dec.
4
Screening for Beta Thalassemia Carrier State Among Women Attending Antenatal Clinic in a Tertiary Care Centre and Framing a Model Program for the Prevention of Beta Thalassemia.在一家三级医疗中心的产前诊所就诊的女性中筛查β地中海贫血携带者状态,并制定预防β地中海贫血的示范项目。
Cureus. 2022 Feb 14;14(2):e22209. doi: 10.7759/cureus.22209. eCollection 2022 Feb.
5
Geographical distribution of β-globin gene mutations in Syria.叙利亚β-珠蛋白基因突变的地理分布。
Hematology. 2018 Oct;23(9):697-704. doi: 10.1080/10245332.2018.1461291. Epub 2018 Apr 11.
6
New trend in the epidemiology of thalassaemia.地中海贫血流行病学的新趋势。
Best Pract Res Clin Obstet Gynaecol. 2017 Feb;39:16-26. doi: 10.1016/j.bpobgyn.2016.10.013. Epub 2016 Oct 26.
7
A systematic analysis of global anemia burden from 1990 to 2010.1990 年至 2010 年全球贫血负担的系统分析。
Blood. 2014 Jan 30;123(5):615-24. doi: 10.1182/blood-2013-06-508325. Epub 2013 Dec 2.
8
Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis.贫血、产前铁剂使用与不良妊娠结局风险:系统评价和荟萃分析。
BMJ. 2013 Jun 21;346:f3443. doi: 10.1136/bmj.f3443.
9
Epidemiological profile of common haemoglobinopathies in Arab countries.阿拉伯国家常见血红蛋白病的流行病学概况。
J Community Genet. 2013 Apr;4(2):147-67. doi: 10.1007/s12687-012-0127-8. Epub 2012 Dec 8.
10
Screening and genetic diagnosis of hemoglobinopathies in southern and northern europe: two examples.欧洲南部和北部的血红蛋白病筛查和基因诊断:两个例子。
Mediterr J Hematol Infect Dis. 2009 Aug 8;1(1):e2009007. doi: 10.4084/MJHID.2009.007.